Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Comparison of Z7200 and Symbicort Turbohaler in Healthy Volunteers
NCT02237508Phase 1Completed
- Sponsor
- Zambon
- Start
- Sep 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of budesonide + formoterol in asthma (10 arms), sponsored by Zambon. Primary endpoints: Area Under the Curve from time 0 to the last measurable concentration (AUC0-t) of Budesonide, Area Under the Curve from time 0 to the last measurable concentration (AUC0-t) of Formoterol and 2 more. Started Sep 2014; status: completed.
02
Drugs
budesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02237508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02237508.